1043 
Influence of HIV, HCV, and HIV/HCV-co-infection on Level, Phenotype, and Activation Status of Foxp3+CD4+ Regulatory T Cells
Norma Rallon*, M Lopez, V Soriano, J Garcia-Samaniego, M Romero, P Labarga, P Garcia-Gasco, J Gonzalez-Lahoz, and J Benito
Hosp Carlos III, Madrid, Spain
Background: HIV and hepatitis C virus (HCV)
infections may alter the population of CD4+ regulatory T (Treg)
cells. This cell subset contributes to viral persistence inhibiting specific T
cell responses. Herein, we report the level, phenotype, and activation status
of Treg cells in patients chronically infected with HIV or HCV.
Methods: We examined 91 subjects: 20 healthy
controls, 20 HIV-mono-infected, 20 HCV-mono-infected, and 31 HIV/HCV-co-infected.
All HCV+ were serum HCV RNA+. Treg cells were defined as
CD4+ T cells expressing Foxp3+. Level, phenotype
(expression of CD25, CD45RA, CD27, and CD127 markers), and activation status
(expression of CD38 marker) of these cells were analyzed using 5-color flow
cytometry. Differences between groups for the different parameters were
assessed using non-parametric tests.
Results: Mean CD4 count and plasma HIV RNA in HIV
patients were 486±267 cells/μL and 2.6±1.4 log copies/mL (67% of them were
on HAART). Mean serum HCV RNA in HCV patients was 6.1±1.1 log IU/mL. Treg cells
were significantly increased in HIV+ patients compared to controls
and HCV-mono-infected (p = 0.01), with no differences between HIV-mono-infected
and HIV/HCV-co-infected patients. In patients and controls only 50% of Treg
cells expressed CD25. Moreover, 95% of CD25+ Treg cells were CD45RA–CD127–
in all groups, whereas CD25– Treg cells were more heterogeneous in
terms of CD45RA and CD127 expression. Overall, 65% of Treg cells were CD45RA–CD27+
(central memory), without differences between controls and patients. However,
naive Treg cells (CD45RA+CD27+) were less frequent in
patients than controls (p = 0.04). In all subjects, activation of Treg
cells was higher than of total CD4+ cells (p <0.005).
Moreover, activation of Treg cells was significantly higher in HIV+
patients than in the rest, specially considering the central memory subset (p
<0.0001). There were no differences when comparing HIV-mono-infected and
HIV/HCV-co-infected patients. Finally, in HIV+ patients there was a
significant and inverse correlation between CD4 counts and the level of Treg
cells (ρ = –0.54; p <0.0001).
Conclusions: HIV infection, but not HCV, induces up-regulation
of highly activated Treg cells. Interestingly, 2 subsets of Treg cells with a
different phenotypic profile may be defined on the basis of CD25 expression.
This up-regulation increases in parallel with CD4 depletion, which
hypothetically might contribute to the accelerated course of liver disease in
HCV/HIV-co-infected patients.
|